Author | Larry Husten, CardioBrief


CardioBrief: Slow Down Urged on SPRINT

March 02, 2016

The 25% reduction in relative risk seen in patients treated to 120 vs 140 mm Hg corresponds to an absolute risk reduction of 1.6%.

New Analyses Only Partly Defuse ROCKET-AF Trial Concerns

February 11, 2016

Critics continue to call for independent analysis by outside investigators not involved with the original trial.

Statin Intolerance Test Faces Skeptics

December 03, 2015

Even experts involved in clinical trials of the at-home saliva test say it has no place in routine clinical practice.